Search

Your search keyword '"Perdue, Andrea"' showing total 14 results
Start Over Author "Perdue, Andrea"
14 results on '"Perdue, Andrea"'

3. Extended duration of anti-PD-1 therapy, using reduced frequency dosing, in patients with advanced melanoma and Merkel cell carcinoma.

Author

Tachiki, Lisa May Ling, primary, Williams Silva, Karly, additional, Hippe, Daniel S, additional, Fritzsche, Dane, additional, Raczka, Aleksandra, additional, Perdue, Andrea, additional, Majovski, Julia, additional, Spallone, Alexandra, additional, Goldstein, Daniel A, additional, Nghiem, Paul, additional, Thompson, John A., additional, Hall, Evan Thomas, additional, and Bhatia, Shailender, additional

Published
2022
Full Text
View/download PDF

4. Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Author

Mabrey, Frances Linzee, primary, Gardner, Kelda M., primary, Shannon Dorcy, Kathleen, primary, Perdue, Andrea, primary, Smith, Heather A., primary, Davis, Alicyn M., primary, Hammer, Cody, primary, Rizzuto, Donelle, primary, Jones, Sunny, primary, Quach, Kim, primary, Scott, Bart L., primary, Hendrie, Paul C., primary, Percival, Mary-Elizabeth M., primary, Walter, Roland B., primary, Appelbaum, Frederick R., primary, Estey, Elihu H., primary, and Becker, Pamela S., primary

Published
2020
Full Text
View/download PDF

5. Assessing Selection Bias in the Assignment to Investigational Acute Myeloid Leukemia (AML) Therapy

Author

Gardner, Kelda, primary, Percival, Mary-Beth, additional, Becker, Pamela, additional, Walter, Roland, additional, Hendrie, Paul, additional, Shaw, Carole, additional, Dhawale, Tejaswini, additional, Halpern, Anna, additional, Scott, Bart, additional, Rosen, Anna, additional, Schiavo, Karen, additional, Zecha, Gabe, additional, Perdue, Andrea, additional, Smith, Heather, additional, Davis, Alisyn, additional, Kjeldahl, Amy, additional, and Estey, Elihu, additional

Published
2017
Full Text
View/download PDF

6. A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Author

Halpern, Anna B., primary, Othus, Megan, additional, Huebner, Emily M, additional, Orlowski, Kaysey F., additional, Scott, Bart L., additional, Smith, Heather A., additional, Becker, Pamela S., additional, Percival, Mary-Elizabeth M., additional, Hendrie, Paul C., additional, Perdue, Andrea M., additional, Chen, Tara L., additional, Buckley, Sarah A., additional, Erba, Harry P., additional, Estey, Elihu H., additional, and Walter, Roland B., additional

Published
2016
Full Text
View/download PDF

7. A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Author

Becker, Pamela S., primary, Chien, Sylvia, additional, Martins, Timothy J, additional, Herstein, Andrew, additional, Hammer, Cody, additional, Sekizaki, Taylor, additional, Oehler, Vivian, additional, Blau, C. Anthony, additional, Patay, Bradley A, additional, Carson, Andrew, additional, Hendrie, Paul C., additional, Walter, Roland B., additional, Percival, Mary-Elizabeth M., additional, Meschinchi, Soheil, additional, Tarlock, Katherine, additional, Cassaday, Ryan D, additional, Gardner, Kelda, additional, Smith, Heather, additional, Perdue, Andrea M., additional, Appelbaum, Frederick R., additional, Radich, Jerald P., additional, and Estey, Elihu H., additional

Published
2016
Full Text
View/download PDF

8. Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): Final Results from a Phase 1/2 Study

Author

Halpern, Anna B., primary, Buckley, Sarah A., additional, Othus, Megan, additional, Huebner, Emily M, additional, Orlowski, Kaysey F., additional, Scott, Bart L, additional, Perdue, Andrea M., additional, Smith, Heather A., additional, Becker, Pamela S., additional, Hendrie, Paul C., additional, Cassone, Stephanie, additional, Chen, Tara L., additional, Stirewalt, Derek L., additional, Estey, Elihu H., additional, and Walter, Roland B., additional

Published
2016
Full Text
View/download PDF

9. Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Author

Anwar, Asma, primary, Halpern, Anna B., additional, Othus, Megan, additional, Scott, Bart L., additional, Hendrie, Paul C., additional, Becker, Pamela S., additional, Perdue, Andrea M., additional, Smith, Heather A., additional, Chen, Tara L., additional, Buckley, Sarah A., additional, Orlowski, Kaysey F., additional, Powell, Morgan A., additional, Estey, Elihu H., additional, and Walter, Roland B., additional

Published
2015
Full Text
View/download PDF

10. Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed AML or High-Risk MDS

Author

Halpern, Anna B., primary, Anwar, Asma, additional, Scott, Bart L., additional, Becker, Pamela S., additional, Othus, Megan, additional, Hendrie, Paul C., additional, Ranker, Elizabeth M., additional, Perdue, Andrea, additional, Smith, Heather A., additional, Chen, Tara L., additional, Buckley, Sarah A., additional, Orlowski, Kaysey F., additional, Powell, Morgan A., additional, Estey, Elihu H., additional, and Walter, Roland B., additional

Published
2015
Full Text
View/download PDF

12. Outpatient Intensive Induction Chemotherapy for Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome

Author

Mabrey, Frances Linzee, Gardner, Kelda M, Shannon Dorcy, Kathleen, Perdue, Andrea, Smith, Heather, Davis, Alicyn Marie, Hammer, Cody, Rizzuto, Donelle, So, Sunny, Rosen, Anna, Quach, Kim, Scott, Bart L., Hendrie, Paul C., Percival, Mary Beth M., Walter, Roland B., Appelbaum, Frederick R., Estey, Elihu H., and Becker, Pamela S.

Abstract

Introduction:

Published
2017
Full Text
View/download PDF

14. A Precision Medicine Approach Incorporating Both Molecular and In VitroFunctional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Author

Becker, Pamela S., Chien, Sylvia, Martins, Timothy J, Herstein, Andrew, Hammer, Cody, Sekizaki, Taylor, Oehler, Vivian, Blau, C. Anthony, Patay, Bradley A, Carson, Andrew, Hendrie, Paul C., Walter, Roland B., Percival, Mary-Elizabeth M., Meschinchi, Soheil, Tarlock, Katherine, Cassaday, Ryan D, Gardner, Kelda, Smith, Heather, Perdue, Andrea M., Appelbaum, Frederick R., Radich, Jerald P., and Estey, Elihu H.

Abstract

Introduction: Acute myeloid leukemia (AML) is a heterogeneous disorder such that each patient exhibits a unique pattern of mutations. Nevertheless, standard treatment approaches are largely used for all patients with the exception of those with the PML-RARAtranslocation or FLT3mutations. We are conducting a feasibility study, "Individualized Treatment for Relapsed/Refractory Acute Leukemia Based on Chemosensitivity and Genomics/Gene Expression Data" (NCT02551718). This abstract summarizes the results in the AML patients.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results